trial · primary record
ION337
Dravet Syndrome
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2030-12 |
| Primary endpoint | Parts 1 and 2: Number of Participants with Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs |
| Registry ID | NCT07531745 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.575Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07531745
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.